Literature DB >> 23786772

Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p.

Stéphanie Solier1, Michael C Ryan, Scott E Martin, Sudhir Varma, Kurt W Kohn, Hongfang Liu, Barry R Zeeberg, Yves Pommier.   

Abstract

Topoisomerase I (Top1) relaxes DNA supercoiling by forming transient cleavage complexes (Top1cc) up- and downstream of transcription complexes. Top1cc can be trapped by carcinogenic and endogenous DNA lesions and by camptothecin, resulting in transcription blocks. Here, we undertook genome-wide analysis of camptothecin-treated cells at exon resolution. RNA samples from HCT116 and MCF7 cells were analyzed with the Affy Exon Array platform, allowing high-resolution mapping along 18,537 genes. Long genes that are highly expressed were the most susceptible to downregulation, whereas short genes were preferentially upregulated. Along the body of genes, downregulation was most important toward the 3'-end and increased with the number of exon-intron junctions. Ubiquitin and RNA degradation-related pathway genes were selectively downregulated. Parallel analysis of microRNA with the Agilent miRNA microarray platform revealed that miR-142-3p was highly induced by camptothecin. More than 10% of the downregulated genes were targets of this p53-dependent microRNA. Our study shows the profound impact of Top1cc on transcription elongation, especially at intron-exon junctions and on transcript stability by microRNA miR-142-3p upregulation. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786772      PMCID: PMC3874869          DOI: 10.1158/0008-5472.CAN-12-3504

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription.

Authors:  B M Shykind; J Kim; L Stewart; J J Champoux; P A Sharp
Journal:  Genes Dev       Date:  1997-02-01       Impact factor: 11.361

3.  CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.

Authors:  G Zoppoli; S Solier; W C Reinhold; H Liu; J W Connelly; A Monks; R H Shoemaker; O D Abaan; S R Davis; P S Meltzer; J H Doroshow; Y Pommier
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867

Review 4.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

5.  Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.

Authors:  Shyamal D Desai; Hui Zhang; Alexandra Rodriguez-Bauman; Jin-Ming Yang; Xiaohua Wu; Murugesan K Gounder; Eric H Rubin; Leroy F Liu
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.

Authors:  Sara A Georges; Matthew C Biery; Soo-Yeon Kim; Janell M Schelter; Jane Guo; Aaron N Chang; Aimee L Jackson; Michael O Carleton; Peter S Linsley; Michele A Cleary; B Nelson Chau
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

8.  Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.

Authors:  F Rossi; E Labourier; T Forné; G Divita; J Derancourt; J F Riou; E Antoine; G Cathala; C Brunel; J Tazi
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

9.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

10.  p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.

Authors:  Ian G Cannell; Yi W Kong; Samantha J Johnston; Melissa L Chen; Hilary M Collins; Helen C Dobbyn; Androulla Elia; Theresia R Kress; Martin Dickens; Michael J Clemens; David M Heery; Matthias Gaestel; Martin Eilers; Anne E Willis; Martin Bushell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

View more
  26 in total

1.  Integrative RNA-seq and microarray data analysis reveals GC content and gene length biases in the psoriasis transcriptome.

Authors:  William R Swindell; Xianying Xing; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  Physiol Genomics       Date:  2014-05-20       Impact factor: 3.107

2.  Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation.

Authors:  Alex Rialdi; Laura Campisi; Nan Zhao; Arvin Cesar Lagda; Colette Pietzsch; Jessica Sook Yuin Ho; Luis Martinez-Gil; Romain Fenouil; Xiaoting Chen; Megan Edwards; Giorgi Metreveli; Stefan Jordan; Zuleyma Peralta; Cesar Munoz-Fontela; Nicole Bouvier; Miriam Merad; Jian Jin; Matthew Weirauch; Sven Heinz; Chris Benner; Harm van Bakel; Christopher Basler; Adolfo García-Sastre; Alexander Bukreyev; Ivan Marazzi
Journal:  Science       Date:  2016-04-28       Impact factor: 47.728

3.  Identification of early gene expression changes in primary cultured neurons treated with topoisomerase I poisons.

Authors:  Sharyn L Rossi; Casey J Lumpkin; Ashlee W Harris; Jennifer Holbrook; Cinsley Gentillon; Suzanne M McCahan; Wenlan Wang; Matthew E R Butchbach
Journal:  Biochem Biophys Res Commun       Date:  2016-09-15       Impact factor: 3.575

Review 4.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

5.  Topoisomerase 1 inhibition reversibly impairs synaptic function.

Authors:  Angela M Mabb; Paul H M Kullmann; Margaret A Twomey; Jayalakshmi Miriyala; Benjamin D Philpot; Mark J Zylka
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 6.  Emerging roles for R-loop structures in the management of topological stress.

Authors:  Frederic Chedin; Craig J Benham
Journal:  J Biol Chem       Date:  2020-02-27       Impact factor: 5.157

Review 7.  Topoisomerase-mediated chromosomal break repair: an emerging player in many games.

Authors:  Mohamed E Ashour; Reham Atteya; Sherif F El-Khamisy
Journal:  Nat Rev Cancer       Date:  2015-02-19       Impact factor: 60.716

8.  NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy.

Authors:  Qiuji Wu; Awatef Allouch; Audrey Paoletti; Celine Leteur; Celine Mirjolet; Isabelle Martins; Laurent Voisin; Frédéric Law; Haithem Dakhli; Elodie Mintet; Maxime Thoreau; Zeinaf Muradova; Mélanie Gauthier; Olivier Caron; Fabien Milliat; David M Ojcius; Filippo Rosselli; Eric Solary; Nazanine Modjtahedi; Eric Deutsch; Jean-Luc Perfettini
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

9.  Zylka et al. reply.

Authors:  Mark J Zylka; Ben D Philpot; Ian F King
Journal:  Nature       Date:  2014-08-07       Impact factor: 49.962

10.  Transcription profiling suggests that mitochondrial topoisomerase IB acts as a topological barrier and regulator of mitochondrial DNA transcription.

Authors:  Ilaria Dalla Rosa; Hongliang Zhang; Salim Khiati; Xiaolin Wu; Yves Pommier
Journal:  J Biol Chem       Date:  2017-10-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.